Nov 19 2014 Scientific Session 304-111-14 Hepcidins Role in Refractory Sideropenic Anemia A Case Study Approach
Scientific Session 304-111-14: Hepcidin's Role in Refractory Sideropenic Anemia: A Case Study Approach
Program Area: Hematology
Level of Instruction: Intermediate
Contact Hours: 1.0
Description: This presentation will examine a rare genetic cause of sideropenic anemia, formally called iron deficiency anemia, in which the patient is unresponsive to traditional oral iron therapy. Hepcidin and Hemojuvelin’s role in iron metabolism will be discussed as related to hemoglobin formation.
To register, please click on "Take Course" below. Course handouts can be downloaded from the link at the bottom of the page.
By the end of the course, the student will be able to:
1. Define the following terms and explain their role in iron metabolism: transferrin, hemosiderin, ferritin, and TIBC.
2. Compare and contrast iron stores, hemoglobin, serum iron, TIBC, serum ferritin, and RBC morphology in the three major stages of iron deficiency anemia.
3. Compare and contrast the roles of hepcidin, HFE, and hemojuvelin in the physiological regulation of iron balance in the body.
4· Describe how genetic defects in the iron metabolism proteins can affect the body’s iron homeostasis.
Dr. Bill Engle, D.D., MS(CLS), MT(ASCP), Associate Professor
Chair, Medical Laboratory Sciences, Lincoln Memorial University
Dr. Engle has indicated he has no financial relationships to disclose relevant to the content of this CE activity
- 1.00 Attendance